Bioorganic and Medicinal Chemistry Letters, volume 29, issue 14, pages 1765-1768

Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection

Publication typeJournal Article
Publication date2019-07-01
Quartile SCImago
Q2
Quartile WOS
Q2
Impact factor2.7
ISSN0960894X, 14643405
Organic Chemistry
Drug Discovery
Biochemistry
Molecular Biology
Pharmaceutical Science
Clinical Biochemistry
Molecular Medicine
Abstract
We report the first biological evaluation the 1,2,3-thiaselenazole class of compound and utilising a concise synthetic approach of sulfur extrusion, selenium insertion of the 1,2,3-dithiazoles. We created a small diverse library of compounds to contrast the two ring systems. This approach has highlighted new structure activity relationship insights and lead to the development of sub-micro molar anti-viral compounds with reduced toxicity. The 1,2,3-thiaselenazole represents a new class of potential compounds for the treatment of FIV and HIV.

Citations by journals

1
2
3
Antibiotics
Antibiotics, 3, 12.5%
Antibiotics
3 publications, 12.5%
Molecules
Molecules, 3, 12.5%
Molecules
3 publications, 12.5%
Bioorganic and Medicinal Chemistry
Bioorganic and Medicinal Chemistry, 2, 8.33%
Bioorganic and Medicinal Chemistry
2 publications, 8.33%
Drug Discovery Today
Drug Discovery Today, 2, 8.33%
Drug Discovery Today
2 publications, 8.33%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 2, 8.33%
European Journal of Medicinal Chemistry
2 publications, 8.33%
Current Medicinal Chemistry
Current Medicinal Chemistry, 1, 4.17%
Current Medicinal Chemistry
1 publication, 4.17%
MolBank
MolBank, 1, 4.17%
MolBank
1 publication, 4.17%
Bioorganic and Medicinal Chemistry Letters
Bioorganic and Medicinal Chemistry Letters, 1, 4.17%
Bioorganic and Medicinal Chemistry Letters
1 publication, 4.17%
ChemistrySelect
ChemistrySelect, 1, 4.17%
ChemistrySelect
1 publication, 4.17%
New Journal of Chemistry
New Journal of Chemistry, 1, 4.17%
New Journal of Chemistry
1 publication, 4.17%
Journal of Structural Chemistry
Journal of Structural Chemistry, 1, 4.17%
Journal of Structural Chemistry
1 publication, 4.17%
Advances in Heterocyclic Chemistry
Advances in Heterocyclic Chemistry, 1, 4.17%
Advances in Heterocyclic Chemistry
1 publication, 4.17%
ACS Omega
ACS Omega, 1, 4.17%
ACS Omega
1 publication, 4.17%
Expert Opinion on Drug Discovery
Expert Opinion on Drug Discovery, 1, 4.17%
Expert Opinion on Drug Discovery
1 publication, 4.17%
Russian Journal of General Chemistry
Russian Journal of General Chemistry, 1, 4.17%
Russian Journal of General Chemistry
1 publication, 4.17%
1
2
3

Citations by publishers

1
2
3
4
5
6
7
8
Elsevier
Elsevier, 8, 33.33%
Elsevier
8 publications, 33.33%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 7, 29.17%
Multidisciplinary Digital Publishing Institute (MDPI)
7 publications, 29.17%
Pleiades Publishing
Pleiades Publishing, 2, 8.33%
Pleiades Publishing
2 publications, 8.33%
Bentham Science
Bentham Science, 1, 4.17%
Bentham Science
1 publication, 4.17%
Wiley
Wiley, 1, 4.17%
Wiley
1 publication, 4.17%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 4.17%
Royal Society of Chemistry (RSC)
1 publication, 4.17%
American Chemical Society (ACS)
American Chemical Society (ACS), 1, 4.17%
American Chemical Society (ACS)
1 publication, 4.17%
Taylor & Francis
Taylor & Francis, 1, 4.17%
Taylor & Francis
1 publication, 4.17%
1
2
3
4
5
6
7
8
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Asquith C. R. M. et al. Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection // Bioorganic and Medicinal Chemistry Letters. 2019. Vol. 29. No. 14. pp. 1765-1768.
GOST all authors (up to 50) Copy
Asquith C. R. M., Meili T., Baranovsky I. V., Konstantinova L. S., Poso A., Rakitin O. A., Hofmann-Lehmann R. Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection // Bioorganic and Medicinal Chemistry Letters. 2019. Vol. 29. No. 14. pp. 1765-1768.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.bmcl.2019.05.016
UR - https://doi.org/10.1016%2Fj.bmcl.2019.05.016
TI - Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection
T2 - Bioorganic and Medicinal Chemistry Letters
AU - Asquith, Christopher R M
AU - Meili, Theres
AU - Rakitin, Oleg A.
AU - Baranovsky, Ilia V
AU - Konstantinova, Lidia S.
AU - Poso, Antti
AU - Hofmann-Lehmann, Regina
PY - 2019
DA - 2019/07/01 00:00:00
PB - Elsevier
SP - 1765-1768
IS - 14
VL - 29
SN - 0960-894X
SN - 1464-3405
ER -
BibTex |
Cite this
BibTex Copy
@article{2019_Asquith,
author = {Christopher R M Asquith and Theres Meili and Oleg A. Rakitin and Ilia V Baranovsky and Lidia S. Konstantinova and Antti Poso and Regina Hofmann-Lehmann},
title = {Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection},
journal = {Bioorganic and Medicinal Chemistry Letters},
year = {2019},
volume = {29},
publisher = {Elsevier},
month = {jul},
url = {https://doi.org/10.1016%2Fj.bmcl.2019.05.016},
number = {14},
pages = {1765--1768},
doi = {10.1016/j.bmcl.2019.05.016}
}
MLA
Cite this
MLA Copy
Asquith, Christopher R. M., et al. “Synthesis and comparison of substituted 1,2,3-dithiazole and 1,2,3-thiaselenazole as inhibitors of the feline immunodeficiency virus (FIV) nucleocapsid protein as a model for HIV infection.” Bioorganic and Medicinal Chemistry Letters, vol. 29, no. 14, Jul. 2019, pp. 1765-1768. https://doi.org/10.1016%2Fj.bmcl.2019.05.016.
Found error?